Gayer Charles K — SEC Form 4 filings
SEC reporting owner CIK 1800110. 6 Form 4 filings on record with FilingPulse; latest filed 2025-12-23.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-05-15 to 2025-12-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 30,000 shares, $164,100 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 30,000 shares @ $5.47 ($164,100) in BIOCRYST PHARMACEUTICALS INC, filed 2024-05-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC (BCRX) | President and CCO | 6 | 1 leg · 30,000 sh · $164,100 | — | 14 |
Form 4 filings — Gayer Charles K
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-23 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Tax withholding (F): 11,477 @ $7.41 · Option exercise (M): 14,142 @ $3.22 · Option exercise (M): 10,091 @ $5.04 · Option exercise (M): 50,000 @ $5.51 · Option exercise (M): 14,142 (derivative) @ $0 · Option exercise (M): 10,091 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-19 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 471,000 @ $0 · Grant/award (A): 986,950 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Tax withholding (F): 8,181 @ $7.57 | EDGAR |
| 2024-12-23 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 125,950 @ $0 · Tax withholding (F): 2,461 @ $7.39 · Grant/award (A): 260,950 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Tax withholding (F): 8,251 @ $7.53 | EDGAR |
| 2024-05-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Purchase (P): 30,000 @ $5.47 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1800110 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →